Infants who received preemptive intervention had lower odds of meeting diagnostic criteria at age 3 years
MONDAY, Sept. 27, 2021 (HealthDay News) — A preemptive intervention reduces behaviors associated with autism spectrum disorder (ASD) when used at the time atypical development first emerges during infancy, according to a study published online Sept. 20 in JAMA Pediatrics.
Andrew J.O. Whitehouse, Ph.D., from the Telethon Kids Institute in Nedlands, Australia, and colleagues assessed the efficacy of a preemptive intervention for ASD beginning during the prodromal period. The analysis included infants (aged 9 to 14 months) showing early behaviors associated with later ASD who were randomly assigned to either a preemptive intervention (10-session social communication intervention, iBASIS-Video Interaction to Promote Positive Parenting [iBASIS-VIPP]) plus usual care (50 infants) or usual care only (53 infants) during a five-month period.
The researchers found that the preemptive iBASIS-VIPP intervention led to a reduction in ASD symptom severity (area between curves, −5.53) and reduced odds of ASD classification at age 3 years (iBASIS-VIPP group: 6.7 percent versus 20.5 percent in the usual care group; odds ratio, 0.18). To reduce ASD classification, the number needed to treat was 7.2 participants. In the iBASIS-VIPP group, there were improvements noted in caregiver responsiveness and language outcomes.
“The combination of a significant treatment effect with maintenance up to 18 months after intervention provides initial evidence of efficacy for a new clinical model that uses a specific developmentally focused intervention among infants at higher likelihood of developing ASD,” the authors write.
Several authors were involved in the development of the iBASIS-VIPP intervention.
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring
Better Youth Fitness May Lower Risk for Depression in Adulthood
Mom"s Poor Sleep in Late Pregnancy Linked to Offspring"s Obesity Risk in Early Childhood
Altered Markers of Ovarian Development Seen With Fetal Acetaminophen Exposure
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy
IBD Not Linked to Risk for Hypertensive Disorders of Pregnancy Overall
Maternal Vitamin D Status Linked to Preterm Delivery